Australian technology – a 4D, X-ray fluoroscopy-based take on lung function testing – can help pinpoint regional deficits in lung function that global measures such as spirometry cannot. Presented at the ATS 2018 International Conference and with FDA approval pending, 4Dx will have application in both early detection of disease and management of disease progression. ...
Already a member?
Enter your email to keep reading.